Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 9, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 22
- 0 vs. Q3 2022
- Portfolio value
- $343.7M
- +$3.89M (+1.1%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LEGNLegend Biotech Corp | SPONSORED ADS | 1,629,173 | $81.3M | 23.7% | 00.0% | Unchanged | History |
| CVRXCVRx, Inc. | COM | 3,495,575 | $64.1M | 18.7% | 00.0% | Unchanged | History |
| MGTXMeiraGTx Holdings plc | COM | 6,641,064 | $43.3M | 12.6% | +3,742,514+129.1% | Added | History |
| FATEFate Therapeutics Inc | COM | 3,379,064 | $34.1M | 9.9% | 00.0% | Unchanged | History |
| PTGXProtagonist Therapeutics, Inc | COM | 2,449,183 | $26.7M | 7.8% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 748,062 | $19.5M | 5.7% | 00.0% | Unchanged | History |
| PRCTPROCEPT BioRobotics Corp | COM | 357,939 | $14.9M | 4.3% | −505,969−58.6% | Reduced | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 3,670,516 | $11.6M | 3.4% | 00.0% | Unchanged | History |
| HLTHCue Health Inc. | COM | 5,548,864 | $11.5M | 3.3% | 00.0% | Unchanged | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 247,598 | $10.0M | 2.9% | 00.0% | Unchanged | History |
| PNTPOINT Biopharma Global Inc. | COM | 1,000,000 | $7.29M | 2.1% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 1,074,658 | $7.15M | 2.1% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 728,944 | $6.52M | 1.9% | 00.0% | Unchanged | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 394,834 | $2.75M | 0.8% | 00.0% | Unchanged | History |
| NNOXNano-X Imaging Ltd. | ORD SHS | 196,228 | $1.45M | 0.4% | +3,799+2.0% | Added | History |
| SLGCSomaLogic, Inc. | CLASS A COM | 281,052 | $705.0K | 0.2% | 00.0% | Unchanged | History |
| HLSQTessera Defense & Homeland Security Inc. | COM | 2,133,402 | $398.0K | 0.1% | 00.0% | Unchanged | History |
| CLSDClearside Biomedical, Inc. | COM | 169,629 | $190.0K | 0.1% | +169,629 | New | History |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 84,003 | $125.0K | <0.1% | 00.0% | Unchanged | History |
| SENSSenseonics Holdings, Inc. | COM | 54,621 | $56.0K | <0.1% | 00.0% | Unchanged | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 66,951 | $35.0K | <0.1% | 00.0% | Unchanged | History |
| CALCCalciMedica, Inc. | COM SHS | 49,547 | $25.0K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q3 2022 (1)
Positions held at the end of Q3 2022 that are gone from this filing.